GB1230472A - - Google Patents

Info

Publication number
GB1230472A
GB1230472A GB3128368A GB3128368A GB1230472A GB 1230472 A GB1230472 A GB 1230472A GB 3128368 A GB3128368 A GB 3128368A GB 3128368 A GB3128368 A GB 3128368A GB 1230472 A GB1230472 A GB 1230472A
Authority
GB
United Kingdom
Prior art keywords
july
carbon atoms
fatty acids
peptide
corticotropically
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB3128368A
Other languages
English (en)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of GB1230472A publication Critical patent/GB1230472A/en
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/33Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • A61K38/35Corticotropin [ACTH]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0043Nose

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Otolaryngology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
GB3128368A 1967-07-10 1968-07-01 Expired GB1230472A (enExample)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH977467 1967-07-10

Publications (1)

Publication Number Publication Date
GB1230472A true GB1230472A (enExample) 1971-05-05

Family

ID=4355521

Family Applications (1)

Application Number Title Priority Date Filing Date
GB3128368A Expired GB1230472A (enExample) 1967-07-10 1968-07-01

Country Status (9)

Country Link
US (1) US3632743A (enExample)
BE (1) BE717820A (enExample)
CY (1) CY752A (enExample)
DE (1) DE1767927A1 (enExample)
FR (2) FR8155M (enExample)
GB (1) GB1230472A (enExample)
IE (1) IE32559B1 (enExample)
MY (1) MY7400210A (enExample)
NL (1) NL6809695A (enExample)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3862928A (en) * 1969-07-09 1975-01-28 Akzona Inc Psychopharmacological hexa-peptides containing a d-phenylalanyl residue
US3954975A (en) * 1972-02-17 1976-05-04 Ciba-Geigy Corporation Salts of ACTH-peptides and processes for their manufacture
BE795788A (nl) * 1972-02-22 1973-08-22 Akzo Nv Werkwijze ter bereiding van peptiden en peptide-derivaten en de toepassing hiervan
US3856770A (en) * 1972-03-08 1974-12-24 Akzona Inc Psychopharmacologically active tetra-, penta-, hexa-, and heptapeptides
NL175618C (nl) * 1972-07-15 1984-12-03 Akzo Nv Werkwijze ter bereiding van een farmaceutisch preparaat met psychofarmacologische werking, dat een peptide of peptide-derivaat bevat, alsmede een werkwijze ter bereiding van dergelijke peptiden.
DE2254043C2 (de) * 1972-11-04 1985-01-24 Hoechst Ag, 6230 Frankfurt LH-Releasing Hormon zur nasalen Applikation
JPS59163313A (ja) * 1983-03-09 1984-09-14 Teijin Ltd 経鼻投与用ペプチドホルモン類組成物
US4576646A (en) * 1983-07-06 1986-03-18 Seppic Film-forming compositions for enveloping solid forms, particularly pharmaceutical or food products or seeds, and products obtained, coated with said compositions
IT1218472B (it) * 1985-08-30 1990-04-19 Alfio Bertolini Composizioni farmaceutiche comprendenti acht (1-24) per il trattamento terapeutico degli stati di shock e dell'insufficienza respiratoria e cardiocircolatoria
IT1204434B (it) * 1986-01-15 1989-03-01 Alfio Bertolini Composizioni farmaceutiche comprendenti frammenti di acth per il trattamento terapeutico degli stati di shock e dell'insufficienza respiratoria e cardiocircolatoria
DE69530325T2 (de) 1994-12-22 2004-02-19 Astrazeneca Ab Aerosol-arzneiformulierungen
US6524557B1 (en) 1994-12-22 2003-02-25 Astrazeneca Ab Aerosol formulations of peptides and proteins
US6264974B1 (en) 1998-07-07 2001-07-24 Salvagnini Italia Spa Buccal and sublingual administration of physostigmine
US6660715B2 (en) 1998-11-19 2003-12-09 Massachusetts Institute Of Technology Nonaqueous solutions and suspensions of macromolecules for pulmonary delivery
AU2003287488B8 (en) * 2002-11-12 2007-05-17 Teva Pharmaceutical Industries Ltd. Pharmaceutical compositions and dosage forms for buccal and sublingual delivery of tizanidine and methods of administering tizanidine sublingually or bucally
DE102006053374A1 (de) * 2006-02-09 2007-08-16 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pharmazeutische Formulierung für Aerosole mit zwei oder mehr Wirkstoffen und mindestens einer oberflächenaktiven Substanz
TW200815048A (en) * 2006-06-05 2008-04-01 Verus Pharmaceuticals Inc Methods for buccal, lingual or sublingual dosing regimens of epinephrine for the treatment of allergic emergencies
US20070293582A1 (en) * 2006-06-05 2007-12-20 Malcolm Hill Epinephrine dosing regimens comprising buccal, lingual or sublingual and injectable dosage forms
EP2077132A1 (en) 2008-01-02 2009-07-08 Boehringer Ingelheim Pharma GmbH & Co. KG Dispensing device, storage device and method for dispensing a formulation
US10011906B2 (en) 2009-03-31 2018-07-03 Beohringer Ingelheim International Gmbh Method for coating a surface of a component
US9265910B2 (en) 2009-05-18 2016-02-23 Boehringer Ingelheim International Gmbh Adapter, inhalation device, and nebulizer
WO2011064163A1 (en) 2009-11-25 2011-06-03 Boehringer Ingelheim International Gmbh Nebulizer
AP3141A (en) 2009-11-25 2015-02-28 Boehringer Ingelheim Int Nebulizer
US10016568B2 (en) 2009-11-25 2018-07-10 Boehringer Ingelheim International Gmbh Nebulizer
US9943654B2 (en) 2010-06-24 2018-04-17 Boehringer Ingelheim International Gmbh Nebulizer
WO2012130757A1 (de) 2011-04-01 2012-10-04 Boehringer Ingelheim International Gmbh Medizinisches gerät mit behälter
US9827384B2 (en) 2011-05-23 2017-11-28 Boehringer Ingelheim International Gmbh Nebulizer
WO2013152894A1 (de) 2012-04-13 2013-10-17 Boehringer Ingelheim International Gmbh Zerstäuber mit kodiermitteln
JP6643231B2 (ja) 2013-08-09 2020-02-12 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング ネブライザ
EP2835146B1 (en) 2013-08-09 2020-09-30 Boehringer Ingelheim International GmbH Nebulizer
DK3139979T3 (da) 2014-05-07 2023-10-09 Boehringer Ingelheim Int Enhed, forstøver og fremgangsmåde
EP3139984B1 (en) 2014-05-07 2021-04-28 Boehringer Ingelheim International GmbH Nebulizer
CN106456913B (zh) 2014-05-07 2019-08-30 勃林格殷格翰国际有限公司 喷雾器和容器

Also Published As

Publication number Publication date
NL6809695A (enExample) 1969-01-14
CY752A (en) 1974-08-31
BE717820A (enExample) 1969-01-09
IE32559B1 (en) 1973-09-19
IE32559L (en) 1969-01-10
US3632743A (en) 1972-01-04
FR8156M (enExample) 1970-08-24
DE1767927A1 (de) 1971-09-30
MY7400210A (en) 1974-12-31
FR8155M (enExample) 1970-08-24

Similar Documents

Publication Publication Date Title
GB1230472A (enExample)
ES8203385A1 (es) Procedimiento de obtencion de nuevos derivados de la vin- blastina
DE69531204D1 (de) Formulierungen fuer faktor ix
ES8504455A1 (es) Procedimiento para preparar implantados que contienen un peptido regulador o uno de sus compuestos analogos
AU6819294A (en) Oral drug delivery compositions and methods
SE8007763L (sv) Sett att framstella en polypeptid
HUP0000589A2 (hu) Vizes peptid készítmények
HUP9802320A2 (hu) Makrolidok, eljárás előállításukra és makrolidokat tartalmazó gyógyszerkészítmények
KR940005669A (ko) 사이클로펩타이드, 및 점막에 적용시 흡수 촉진제로서의 이의 용도
DE3261304D1 (en) Retro-inverso analogues of c-terminal penta and hexapeptides of substance p.
ES8407012A1 (es) Un procedimiento para la preparacion del derivado peptidico ciclico a-21978c.
EP0161007A3 (en) Retro - inverso c-terminal hexapeptide analogues of substance p
GB1109086A (en) Polypeptides
ATE110570T1 (de) Nephroprotektive infusionslösung.
ES8707550A1 (es) Un procedimiento para preparar compuestos peptidicos sustituidos.
IE41078B1 (en) Herbicidal compositions
ES8504434A1 (es) Procedimiento para preparar una composicion fungicida a base de una sal de acido alquil-fosforoso
GB1000718A (en) New hexapeptide
ES483087A1 (es) Procedimiento para la obtencion de bencimidazolcarbamatos
BG30616A3 (en) Fungicide means and method for fungus fighting
ES418158A1 (es) Un procedimiento de preparacion de nuevos peptidos.
ES417951A1 (es) Un procedimiento para la preparacion de nuevos peptidos de actividades acth.
ATE91286T1 (de) Gefaessaktive peptide.
GB1514113A (en) Therapeutic compositions containing dimercapto-diethyl ether derivatives
HUT49621A (en) Insecticides comprising thionophosphoric acid ester as active ingredient and process for producting the active ingredients

Legal Events

Date Code Title Description
PS Patent sealed [section 19, patents act 1949]
PCNP Patent ceased through non-payment of renewal fee